New allergy drug aims to clear noses and help asthma sufferers breathe easier
NCT ID NCT07168473
First seen Nov 01, 2025 · Last updated Apr 28, 2026 · Updated 21 times
Summary
This study tests two allergy medications, DW1807 and DW1807-R2, in 274 adults who have year-round nasal allergies and asthma. The goal is to see which one better reduces nasal symptoms like stuffiness and runny nose over 4 weeks. Participants must have had allergies for at least 2 years and test positive for common allergens.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PERENNIAL ALLERGIC RHINITIS ACCOMPANIED BY ASTHMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Konkuk University Medical Center
RECRUITINGSeoul, South Korea
Conditions
Explore the condition pages connected to this study.